Britta Weigelt

2002–2026 年に発表

252
論文数
34,196
被引用数
99
h 指数
235
i10 指数

被引用数

Britta Weigelt の年別被引用数1926 年: 被引用 1 件1985 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1996 年: 被引用 1 件1998 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 6 件2004 年: 被引用 32 件2005 年: 被引用 71 件2006 年: 被引用 110 件2007 年: 被引用 146 件2008 年: 被引用 177 件2009 年: 被引用 182 件2010 年: 被引用 293 件2011 年: 被引用 282 件2012 年: 被引用 242 件2013 年: 被引用 204 件2014 年: 被引用 285 件2015 年: 被引用 339 件2016 年: 被引用 380 件2017 年: 被引用 432 件2018 年: 被引用 432 件2019 年: 被引用 1,276 件2020 年: 被引用 1,441 件2021 年: 被引用 1,450 件2022 年: 被引用 1,162 件2023 年: 被引用 1,021 件2024 年: 被引用 1,602 件2025 年: 被引用 868 件2026 年: 被引用 33 件1927〜1984 年は被引用が無いため表示していません1986〜1992 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません1999〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,450 件、この内訳の 26.9%中国: 引用元論文 1,816 件、この内訳の 11%イギリス: 引用元論文 1,163 件、この内訳の 7.1%イタリア: 引用元論文 929 件、この内訳の 5.6%ドイツ: 引用元論文 713 件、この内訳の 4.3%フランス: 引用元論文 627 件、この内訳の 3.8%カナダ: 引用元論文 624 件、この内訳の 3.8%スペイン: 引用元論文 545 件、この内訳の 3.3%オランダ: 引用元論文 500 件、この内訳の 3%オーストラリア: 引用元論文 430 件、この内訳の 2.6%日本: 引用元論文 378 件、この内訳の 2.3%スイス: 引用元論文 349 件、この内訳の 2.1%
0%26.9%その他 24.2%

分野

  • Biochemistry, Genetics and Molecular Biology46.8%
  • Medicine45.3%
  • Immunology and Microbiology2.2%
  • Engineering1.8%
  • Computer Science1.6%
  • Materials Science0.5%
  • その他1.8%

トピック

  • Cancer Genomics and Diagnostics7.2%
  • Cancer Cells and Metastasis4.3%
  • Breast Cancer Treatment Studies3.9%
  • HER2/EGFR in Cancer Research2.2%
  • Cancer Immunotherapy and Biomarkers2.2%
  • Endometrial and Cervical Cancer Treatments2.1%
  • その他78.1%

共著者

全論文

検索で開く
  1. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 被引用: 663

  2. Diverse alterations associated with resistance to KRAS(G12C) inhibition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 被引用: 447

  3. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 被引用: 1,006

  4. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

    著者: , , , , , , , , , , , , , , - Science Translational Medicine 2015 被引用: 1,132

  5. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2015 被引用: 858

  6. Ovarian cancer mutational processes drive site-specific immune evasion

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yukio Sonoda, Oliver Zivanovic, Ritika Kundra, Agnès Viale, Fatemeh Derakhshan, Luke Geneslaw, Shirin Issa Bhaloo, Ana Maroldi, Rahelly Nunez, Fresia Pareja, Anthe A. Stylianou, Mahsa Vahdatinia, Yonina Bykov, Rachel N. Grisham, Ying L. Liu, Yulia Lakhman, Ines Nikolovski, Daniel J. Kelly, Jianjiong Gao, Andrea Schietinger, Travis J. Hollmann, Samuel F. Bakhoum, Robert A. Soslow, Lora H. Ellenson, Nadeem R. Abu‐Rustum, Carol Aghajanian, Claire F. Friedman, Andrew McPherson, Britta Weigelt, Dmitriy Zamarin, Sohrab P. Shah - Nature 2022 被引用: 307

  7. Breast cancer metastasis: markers and models

    著者: , , - Nature reviews. Cancer 2005 被引用: 2,247

  8. Single-cell genomic variation induced by mutational processes in cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viktoria Bojilova, Richard A. Moore, Nicole Rusk, Florian Uhlitz, Nicholas Ceglia, Adam C. Weiner, Elena Zaikova, J. Maxwell Douglas, Dmitriy Zamarin, Britta Weigelt, Sarah H. Kim, Arnaud Da Cruz Paula, Jorge S. Reis‐Filho, Spencer D. Martin, Yangguang Li, Hongxia Xu, Teresa Ruiz de Algara, So Ra Lee, Viviana Cerda Llanos, David G. Huntsman, Jessica N. McAlpine, Gregory J. Hannon, Georgia Battistoni, Dario Bressan, Ian G. Cannell, Hannah Casbolt, Cristina Jauset, Tatjana Kovačević, Claire M. Mulvey, Fiona Nugent, Marta Ribes, Isabella Pearson, Fatime Qosaj, Kirsty Sawicka, Sophia A. Wild, Elena Williams, Emma Laks, Austin Smith, Daniel Lai, Andrew Roth, Shankar Balasubramanian, Maximilian Lee, Bernd Bodenmiller, Marcel Burger, Laura Kuett, Sandra Tietscher, Jonas Windhager, Edward S. Boyden, Shahar Alon, Yi Cui, Amauche Emenari, Daniel Goodwin, Emmanouil D. Karagiannis, Anubhav Sinha, Asmamaw T. Wassie, Carlos Caldas, Alejandra Bruna, Maurizio Callari, Wendy Greenwood, Giulia Lerda, Yaniv Eyal-Lubling, Oscar M. Rueda, Abigail Shea, Owen Harris, Robby Becker, Flaminia Grimaldo, Suvi Harris, Sara Lisa Vogl, Johanna A. Joyce, Spencer S. Watson ほか 20 名 - Nature 2022 被引用: 152

  9. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging

    著者: , , , , , , , - Clinical Radiology 2016 被引用: 358

  10. Epigenetic dysregulation from chromosomal transit in micronuclei

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yael David, Samuel F. Bakhoum - Nature 2023 被引用: 115

  11. Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisa de Stanchina, Scott W. Lowe, Neal Rosen, Sandra Misale - Cancer Discovery 2022 被引用: 138

  12. Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra Snyder, Britta Weigelt, Evis Sala, Martin L. Miller - Nature Genetics 2020 被引用: 253

  13. Classification of endometrial carcinoma: more than two types

    著者: , , - The Lancet Oncology 2014 被引用: 663

  14. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 被引用: 69

  15. Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 129

  16. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 被引用: 210

  17. Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 258

  18. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , - Gynecologic Oncology 2023 被引用: 88

  19. Histological types of breast cancer: How special are they?

    著者: , , - Molecular Oncology 2010 被引用: 558

  20. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

    著者: , , , , , , , , , , , , , , , , , , - Annals of Oncology 2014 被引用: 378

  21. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 被引用: 210

  22. Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Anglesio, David G. Huntsman, Simon A. Gayther, Jason Konner, Francesmary Modugno, Kate Lawrenson, Ellen L. Goode, Elli Papaemmanuil - Clinical Cancer Research 2022 被引用: 103

  23. Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 94

  24. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

    著者: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2022 被引用: 83